NovaScan Lung Studies Published in a Leading Peer Reviewed Journal

NovaScan, a clinical-stage oncology company based in Chicago and Milwaukee, recently had its publication titled "The Cole Relaxation Frequency as a Parameter to Identify Cancer in Lung Tissue: Preliminary Animal and ex vivo Patient Studies" accepted in the highly...

NovaScan Completes $8MM Series B Financing

CHICAGO, IL, USA, November 17, 2021 /EINPresswire.com/ -- NovaScan, a clinical stage oncology company pioneering a new low cost point of care platform for cancer detection and treatment, announced that it has completed a $8 Million Series B financing, led by Builders...

NovaScan Fully Subscribes and Completes $3MM Financing

NovaScan, an emerging oncology company based in Chicago and Milwaukee, has announced that it has completed a $3MM financing. The convertible note financing was originally targeted for $2MM, but demand exceeded that amount and the company opportunistically added...